These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 5606066)

  • 1. [Poliomyelitic neutralizing antibodies in Senegal, their formation in subjects already immune and vaccinated with the Sabin virus].
    Barme M; Ceolin G
    Bull Soc Med Afr Noire Lang Fr; 1967; 12(2):320-5. PubMed ID: 5606066
    [No Abstract]   [Full Text] [Related]  

  • 2. [Behavior of poliovirus neutralizing antibodies in 108 subjects vaccinated with the Sabin vaccine].
    Andreoni G; Curatolo D; Cervini E; Rocchi G; Velli V
    G Mal Infett Parassit; 1966 Oct; 18(10):653-7. PubMed ID: 5997193
    [No Abstract]   [Full Text] [Related]  

  • 3. [Isolation of poliovirus in poliomyelitic patients vaccinated with Sabin vaccine].
    Andreoni G; Curatolo D; Cervini E; Provvidenza G; Rocchi G; Velli V
    G Mal Infett Parassit; 1966 Oct; 18(10):662-3. PubMed ID: 4297675
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on poliovirus coproantibody. I. Neutralizing antibodies in feces of children following Sabin oral poliovirus vaccination.
    Kawakami K; Tatsumi H; Tatsumi M; Kono R
    Am J Epidemiol; 1966 Jan; 83(1):1-13. PubMed ID: 5910218
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunization with inactivated poliovirus vaccine and attenuated type 3 poliovirus. II. Parallel vaccinations and cross-wise revaccination in school children with the Sabin and WM3 attenuated strains.
    Böttiger M
    J Pediatr; 1969 Aug; 75(2):273-80. PubMed ID: 4307564
    [No Abstract]   [Full Text] [Related]  

  • 6. Evaluation of poliovirus antibody titers in orally vaccinated semi-captive chimpanzees in Uganda.
    Mugisha L; Pauli G; Opuda-Asibo J; Joseph OO; Leendertz FH; Diedrich S
    J Med Primatol; 2010 Apr; 39(2):123-8. PubMed ID: 20102460
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Levels of specific antibodies against poliomyelitis virus and degree of immune protection in Umbria population].
    Stagni G; Merletti L; De Rosa F
    Boll Ist Sieroter Milan; 1979 Jul; 58(3):210-5. PubMed ID: 229884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serosurvey for polio antibodies.
    Biberi-Moroeanu S; Munţiu A; Stoiculescu S
    Virologie; 1988; 39(4):241-5. PubMed ID: 2851206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Type I poliomyelitis epidemic in France and use of homotypic vaccine (Sabin LSc 2ab). 3. Study of the non-poliomyelitic enteric virus isolated before and after vaccination. Predominance of Coxsackie A7 virus].
    Netter R; Drouhet V; Grist NR; Delpy J
    Arch Gesamte Virusforsch; 1966; 18(1):72-9. PubMed ID: 4294188
    [No Abstract]   [Full Text] [Related]  

  • 10. Mass trivalent oral polio vaccination in primary school age children in Teheran.
    Nategh R; Naficy K; Shahriary M
    Trop Geogr Med; 1970 Sep; 22(3):303-6. PubMed ID: 5470897
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on the neutralization of poliovirus by fecal immunoglobulins. The development of intestinal IgA antibodies following oral poliovirus immunization.
    Keller R; Dwyer JE
    Prog Immunobiol Stand; 1970; 4():316-22. PubMed ID: 4320518
    [No Abstract]   [Full Text] [Related]  

  • 12. [Humoral immunity status against poliomyelitis in the Piedmont population 15 years after the introduction of vaccination with Sabin oral vaccine].
    Giuliani G; Frezet D; Paggi GC; Varetti G
    Ann Sclavo; 1982; 24(1):5-15. PubMed ID: 6303233
    [No Abstract]   [Full Text] [Related]  

  • 13. [Antibody response in subjects vaccinated with a recall dose of the Sabin or Salk type vaccine].
    Squeri L; Calisto ML; Sindoni L; Mattace-Raso G
    Ann Sclavo; 1973; 15(6):569-80. PubMed ID: 4369487
    [No Abstract]   [Full Text] [Related]  

  • 14. [Type I poliomyelitis epidemic in France and use of homotypic vaccine (Sabin I LSc 2 ab) by oral administration. II. Study of the results of vaccination. Characterization of the virus eliminated by the vaccines].
    Boué A; Drouhet V
    Arch Gesamte Virusforsch; 1966; 18(1):59-71. PubMed ID: 4294187
    [No Abstract]   [Full Text] [Related]  

  • 15. [Course of immunity in subjects repeatedly vaccinated with Sabin virus].
    Crovari P; Bori D; De Flora S
    G Ig Med Prev; 1971; 12(1):19-32. PubMed ID: 4340479
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antipoliomyelitic neutralizing antibodies in persons of the Milan region aged 14 to 25 years].
    Braga A; Barbi M
    Ann Sclavo; 1971; 13(3):323-31. PubMed ID: 4340982
    [No Abstract]   [Full Text] [Related]  

  • 17. [Incidence of cytopathogenic enteric viruses in Lombardy 5 years after the introduction of antipoliomyelitic vaccination with the Sabin vaccine].
    Galli MG
    Ann Sclavo; 1971; 13(3):362-9. PubMed ID: 4340984
    [No Abstract]   [Full Text] [Related]  

  • 18. [Complement fixation test after vaccination with live poliomyelitis vaccine (Sabin strains)].
    Terraillon J; Sohier R; Brigaud M; Gramusset J; Laconche N; Blondeau G; Feroldi C
    Ann Inst Pasteur (Paris); 1967 Jan; 112(1):54-64. PubMed ID: 6031425
    [No Abstract]   [Full Text] [Related]  

  • 19. [Virus excretion and antibody formation after double oral poliomyelitis vaccination (Cox triple vaccine and Sabin vaccine)].
    JUST M; BUERGIN-WOLFF A
    Ann Paediatr; 1962; 199():245-9. PubMed ID: 14452877
    [No Abstract]   [Full Text] [Related]  

  • 20. [Status of antipoliomyelitis immunity in 142 children of the Rieti region from 6 months to 3 years after Sabin vaccination].
    Ferranti P; Realmuto A; Marzetti G; Bertolini L; Assensio Biscogli AM; Balducci L; Midulla M
    Ann Sclavo; 1971; 13(3):332-42. PubMed ID: 5153360
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.